Candriam S.C.A. Gilead Sciences, Inc. Transaction History

Candriam S.C.A.

$16.9 Billion
Q4 2024

A detailed history of Candriam S.C.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 1,723,316 shares of GILD stock, worth $165 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

1,723,316

Previous 2,088,287 17.48%

Holding current value

$165 Million

Previous $175 Million 9.06%

% of portfolio

0.94%

Previous 1.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$83.95 - $97.9 $30.6 Million - $35.7 Million	-364,971 Reduced 17.48%	1,723,316 $159 Million
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $4.55 Million - $5.74 Million	68,367 Added 3.38%	2,088,287 $175 Million
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $16.7 Million - $19.3 Million	-265,209 Reduced 11.61%	2,019,920 $139 Million
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $3.21 Million - $3.92 Million	44,892 Added 2.0%	2,285,129 $167 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $53.7 Million - $60.9 Million	732,381 Added 48.57%	2,240,237 $181 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $12.9 Million - $14 Million	-173,939 Reduced 10.34%	1,507,856 $113 Million
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $746,950 - $852,000	9,827 Added 0.59%	1,681,795 $130 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $2.9 Million - $3.3 Million	37,461 Added 2.29%	1,671,968 $139 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $23.5 Million - $33.7 Million	-376,397 Reduced 18.72%	1,634,507 $140 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $1.15 Million - $1.32 Million	-19,355 Reduced 0.95%	2,010,904 $124 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $16.3 Million - $18.3 Million	281,973 Added 16.13%	2,030,259 $125 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $9.36 Million - $11.7 Million	161,573 Added 10.18%	1,748,286 $104 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $1.89 Million - $2.14 Million	29,102 Added 1.87%	1,586,713 $115 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $2.33 Million - $2.52 Million	-34,495 Reduced 2.17%	1,557,611 $109 Million
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $38.9 Million - $42.5 Million	-612,830 Reduced 27.79%	1,592,106 $110 Million
Q1 2021 Apr 29, 2021	SELL	$60.0 - $68.46 $240 - $273	-4 Reduced -0.0%	2,204,936 $123 Million
Q4 2020 Jan 22, 2021	BUY	$56.65 - $64.55 $15.8 Million - $18 Million	279,150 Added 14.5%	2,204,940 $128 Million
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $14.6 Million - $18.4 Million	235,765 Added 13.95%	1,925,790 $122 Million
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $41 Million - $47.6 Million	-566,972 Reduced 25.12%	1,690,025 $130 Million
Q1 2020 May 26, 2020	BUY	$62.63 - $80.22 $2,192 - $2,807	35 Added 0.0%	2,256,997 $143 Million
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $620,328 - $682,341	10,067 Added 0.45%	2,256,962 $147,000
Q3 2019 Feb 05, 2020	SELL	$62.51 - $69.0 $2,187 - $2,415	-35 Reduced -0.0%	2,246,895 $142 Million
Q3 2019 Oct 21, 2019	BUY	$62.51 - $69.0 $16.9 Million - $18.7 Million	270,905 Added 13.71%	2,246,930 $144,000
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $1.44 Million - $1.61 Million	-23,239 Reduced 1.16%	1,976,025 $134 Million
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $26.6 Million - $29.8 Million	425,351 Added 27.03%	1,999,264 $131 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $14.2 Million - $18.5 Million	234,620 Added 17.52%	1,573,913 $98.4 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $31.2 Million - $34.5 Million	437,628 Added 48.54%	1,339,293 $103 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $8.83 Million - $10.3 Million	136,064 Added 17.77%	901,665 $63.9 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $1.59 Million - $1.94 Million	-21,804 Reduced 2.77%	765,601 $57.7 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $24.8 Million - $29.1 Million	-348,796 Reduced 30.7%	787,405 $56.4 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $81.9 Million - $97.1 Million	1,136,201	1,136,201 $92.1 Million

Others Institutions Holding GILD

# of Institutions

1,993

Shares Held

993M

Call Options Held

10.1M

Put Options Held

8.85M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account